A method of applying an elongate magnetic element to the surface of an internal body structure includes applying a magnetic field to the elongate magnetic element to orient the elongate magnetic element in a selected orientation; and applying a magnetic gradient to the elongate magnetic element to draw the elongate magnetic element against the surface of the body structure.
|
1. A medical device adapted to align with an externally applied magnetic field, and be pulled against the surface of an internal body structure by an externally applied magnetic gradient, the medical device comprising:
an elongate magnetic element having first and second ends and comprising a plurality of magnetically responsive bodies spaced along the length of the element, and a tether extending from each end of the elongate magnetic element for restraining the elongate magnetic element against the force of the applied magnetic gradient; the elongate magnetic element has at least first and second faces, and wherein the tethers are secured adjacent the first face, so that under the applied gradient, the second face faces the surface of the body structure.
2. The medical device according to
3. The medical device according to
4. The medical device according to
5. The medical device according to
6. The medical device according to
7. The medical device according to
8. The medical device according to
9. The medical device according to
10. The medical device according to
11. The medical device according to
|
This application is a divisional of U.S. patent application Ser. No. 09/311,686 filed on May 13, 1999, now U.S. Pat. No. 6,292,678. The disclosure of which is incorporated herein by reference.
This invention relates to a method of magnetically navigating medical devices in the body with a combination of a magnetic field and a magnetic gradient, and to medical devices adapted therefor.
Magnets have long been used to navigate objects in the body. The earliest use of magnets was for removing magnetic materials, such as steel shrapnel, from a patient's body. Subsequently, magnets were used to move medical devices in the body. More specifically, magnets have also been used to create a magnetic field in the body for orienting magnetic medical devices, or to create a front field magnetic gradient (i.e., a gradient substantially aligned with the magnetic field) for pulling magnetic medical devices in the body. There are a number of medical applications in which it is desirable to both orient a medical device and apply it against an internal body structure in the selected orientation, for example in cardiac mapping, cardiac pacing, or cardiac ablation procedures. This ability would also be useful in the targeted delivery of therapeutic agents, for example delivery of growth agents for percutaneous myocardio revascularization. While magnetic fields have proven effective for orienting medical devices in the body, and to a lesser extent end field magnetic gradients have proven effective for moving medical devices in the body, its has not been possible to orient a medical device and apply it against an internal body structure in the selected orientation.
The ability to orient and apply a medical device against an internal body structure would have a wide range of medical applications, and particularly in cardiac electrophysiology. There are several types of abnormally rapid heart rhythms, or tachyarrhythmias. Over the past decade, reliable cures for some of these tachyarrhythmias have been developed using catheter-based radio frequency (RF) energy to ablate the piece of cardiac tissue responsible for the arrhythmia. These conditions include Wolfe Parkinson White syndrome and Atrio-Ventricular Nodal Reentrant Tachycardias, where procedural success rates are as high as 99-100%. The catheters used for RF ablation have one or more electrodes at the distal end and typically contain a means for manual mechanical navigation with a heart chamber. The physician uses controls at the proximal end of the catheter to navigate the distal tip to the desired location and to attempt to hold it in constant contact with the heart wall during the application of RF energy.
More recently, much attention has been paid to another cardiac tachyarrhythmia, atrial fibrillation (AF). AF is characterized by a rapid, disorganized beating of both atria. AF affects over 2 million people in the U.S., mostly those over 60. While AF is not acutely life threatening, it can have debilitating symptoms and raises the risk of stoke (via embolized thrombus formed in the stagnant atria) by a factor of 5. The only curative procedure to date for AF is the surgical Maze procedure, developed in the mid-1980's at Washington University in St. Louis. As described in Cox et al., J Thorac Cardiovasc Surg 1995,110, 473-495, (incorporated herein by reference), several transmural incisions are made in both atria (in a particular anatomic pattern), interrupting the fibrillatory "circuits" in the tissue while allowing conduction to proceed in a circuitous path throughout the atria.
Substantial work has been done to attempt to mimic the Maze procedure with a less invasive, percutaneous approach. This work has resulted in the development of a number of "linear lesion catheters." These devices are designed to create transmural linear lesions which mimic the surgical incisions of the Maze procedure. While most use an array of RF electrodes (e.g. Avitall, U.S. Pat. No. 5,730,127; Li et al., U.S. Pat. No. 5,879,295; Schaer, U.S. Pat. No. 5,863,291; Chen et al., U.S. Pat. No. 5,782,828; and Pomeranz et al, U.S. Pat. No. 5,800,482, each of which is incorporated herein by reference) other tissue ablation technologies have also been incorporated into these catheters as well, such as cryogenic ablation (e.g., Avitall, U.S. Pat. No. 5,733,280, incorporated herein by reference), and ultrasound (e.g., Crowley, U.S. Pat. No. 5,630,837, incorporated herein by reference). The "catheter Maze" procedure consists of placing a series of interconnected linear lesions in both atria. For this procedure the catheter must be navigated to, and positioned at, several sites in both atria. Clearly, there is an additional constraint on navigating linear lesion catheters that is not imposed on point ablation catheters: orientation. Not only must the catheter be navigated to the proper location and held there, it must be positioned in the proper orientation.
Prior to this invention, linear lesion catheters have been navigated, positioned and held in place manually via mechanical controls at the proximal end of the catheter. The linear lesion catheters designed to date share one or more of the following problems: Most of these catheters are optimized for some locations and orientations, and are sub-optimal for other orientations. The ability to navigate and position the catheter using mechanical controls is dependent on the tortuosity of the catheter's path to the chamber. The more tortuous the path, less navigational and positional ability remains once the catheter reaches the chamber. The proximal end of the catheter is stationary, while the distal segment is moving with heart chamber, making it difficult to assure good contact of all electrodes, or other lesion making surfaces, throughout the cardiac cycle. For example, if ablation electrodes are not in intimate contact with the walls of the heart, the electrodes can overheat the blood and coagulum can form on the catheter reducing its effectiveness. These limitations have proven particularly problematic when attempting to create lesions in the left atrium.
Also, since the heart wall is moving, the force supplied by traditional catheters to the heart wall varies during the cardiac cycle and the physician cannot quantitatively sense how much force is being exerted against the tissues. As a consequence the mapping and ablating process is not readily reproducible, even for endocardial sites which may be easy to navigate to.
The present invention relates to a method of navigating medical devices in the body which employs both a magnetic field to selectively orient the medical device, and a magnetic gradient to pull the medical device against a selected body structure. Generally the method comprises the steps of applying a magnetic field to the elongate magnetic element to orient the elongate magnetic element in a selected orientation; and applying a magnetic gradient to the elongate magnetic element to draw the elongate magnetic element against the surface of the body structure. The magnetic gradient is preferably oblique to the magnetic field direction, so that the pulling force is at an oblique angle to the aligning force, and more preferably the gradient is perpendicular to the field direction. Thus, the elongate magnetic element is held against the body structure substantially along its length. This can be conveniently done with one or more permanent magnets, using, for example the side field of a single permanent magnet or using the field in the gap of a gapped toroid magnet, but it could also be done with electromagnets, or superconducting electromagnets.
This present invention also relates to a magnetic medical device adapted to be applied to the internal structures of the body. Generally, the medical device includes an elongate magnetic element comprising one or more magnetically responsive bodies. The magnetically responsive bodies can comprise cylinders or coils of a permeable magnetic material or a permanent magnetic material. The magnets are preferably axially polarized so that the elongate magnetic element aligns with an applied magnetic field. The direction of the polarity of the magnet bodies with respect to the longitudinal axis of the elongate magnetic element can vary, to cause the elongate element to bend to facilitate the elongate medical device conforming to the internal body structure to which it is applied. The magnetically responsive bodies could also be spherical magnets, pivotally mounted in the elongate magnetic element so that they can align with the applied magnetic field, still apply an aligning torque to the elongate magnetic element.
The elongate magnetic element can include electrodes for mapping, electrodes for pacing, or electrodescontacts or other elements for tissue ablation. The elongate magnetic element could alternatively or additionally include injectors or simply openings for the delivery of therapeutic or other agents from the medical device, for example growth factors for percutaneous myocardial revasculariation, or simple saline for cooling the electrodes/contacts used in ablation.
The method of the present invention allows an elongate medical device to be precisely oriented and applied to the surface of an internal body structure. This facilitates a number of procedures, including cardiac mapping, cardiac pacing and cardiac ablation. The magnetic field and the oblique magnetic gradient can be easily and economically applied with a single permanent magnet, and thus the method can be employed with relatively inexpensive equipment, although the magnetic field and gradient may be applied with a gapped toroid magnet, or one or more electromagnets or superconducting electromagnets.
These and other features and advantages will be in part apparent, and in part pointed out hereinafter.
Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.
According to the method of the present invention, a magnetic medical device can be oriented and applied to the surface of an internal body structure, such as the wall of the heart in a cardiac mapping, pacing, or ablation procedure. While the method and apparatus described herein relate to the application of medical devices to the heart, the invention is not so limited and the method and apparatus of this invention can be used to apply medical devices to other internal body structures as well. The method comprises applying a magnetic field to the elongate magnetic element to orient the elongate magnetic element in a selected orientation, and applying an approximately transverse magnetic gradient to the elongate magnetic element to draw the elongate magnetic element against the surface of the body structure. The magnetic field and the magnetic gradient are preferably applied simultaneously, using the side field of a magnet. The side field of a magnet has a magnetic gradient oblique to the magnetic field direction, and thus is useful in aligning a magnetic medical device with the magnetic field, and pulling the magnetic medical device in an oblique direction.
The magnetic field and gradient can be simultaneously applied with a single permanent magnet, a pair of permanent magnets (for example in a gapped toroid arrangement), a single electromagnetic coil (preferably a superconducting electromagnetic coil), or a pair of electromagnetic coils (preferably superconducting electromagnetic coils).
The orientation of the elongate magnetic element can be changed by changing the direction of the applied magnetic field. This can be done by moving or changing the orientation of the source of the applied magnetic field and gradient.
As shown in
The side field of the magnet M is capable of creating a magnetic field and an oblique magnetic gradient in an operating region in a patient, to control a magnetic medical device in the operating region in a patient. The medical device is localized in the operating region, for example with bi-planar fluoroscopy, ultrasonic time-of-flight, or electromagnetic means, so that the physician can monitor the location and orientation of the device in space, or relative to the tissue to be interacted with (using whatever visualization is provided as part of the magnetic navigation system). The physician can then manually orient the magnet; input desired orientation and direction of movement to a computer controller that operates an articulated arm to orient the magnet; or otherwise control the position and orientation of the source of the magnetic field and gradient.
Referring to
As shown in
Markers 40 on the catheter 30, positioned, for example at the ends of the elongate magnetic element 36, help the physician visualize the catheter and thereby properly position and orient the catheter. The markers 40 could be radio-opaque where the catheter is localized with fluoroscopy; ultrasonic transducers, where the catheter is localized using ultrasonic time-of-flight; electromagnetic means, where the catheter is localized using electromagnetic field sensing; or some other type of marker for localizing the catheter.
By locating the catheter 30 with the markers 40, the force applied to the catheter can be calculated knowing the relationship (distance and angle) between the catheter and the source of the magnetic field, and thus the physician can know the force holding the catheter in contact with the wall W of the chamber of the heart. The torque on the catheter can also be calculated knowing the location and orientation of the distal segment and the angle of the applied magnetic field. The physician can manipulate the magnet to control the amount of force that the catheter 30 applies to the wall of the heart, to ensure proper contact between the contacts 38 or other devices provided on the elongate magnetic element 36 for conducting the medical procedure. Prior to this invention, achieving a specified minimum contact pressure between a catheter and a moving structure such as the heart wall, was extremely difficult.
Referring to
As shown in
Markers 64 on the catheter 50, positioned for example at the ends of the elongate magnetic element 56, help the physician visualize the catheter and thereby properly position and orient the catheter. The markers 64 could be radio-opaque where the catheter is localized with fluoroscopy; ultrasonic transducers where the catheter is localized using ultrasonic time-of-flight; electromagnetic means where the catheter is localized using electromagnetic field sensing or some other type of marker for localizing the catheter.
By locating the catheter 50 with the markers 64, the force applied to the catheter can be calculated knowing the relationship (distance and angle) between the catheter and the source of the magnetic field, and thus the physician can know the force holding the catheter in contact with the wall of the chamber of the heart. The torque on the catheter tip can also be calculated knowing the orientation and location of the distal segment and the magnitude and orientation of the applied magnetic field. The physician can manipulate the magnet to control the amount of force the catheter 50 applies to the wall of the heart, to ensure proper contact between the contacts 62 or other devices provided on the elongate magnetic element 50 for conducting the medical procedure.
As shown in
As shown in
As indicated above, the magnetic medical device, such as catheter 30 or 50, is navigated to the operating region, e.g., the chamber C of the heart. This can be conveniently done by putting the medical device in the distal end 82 of a sheath 80. The distal end 82 of the sheath 80 is navigated to the site, either mechanically, or magnetically (using the elongate magnetic elements). Once the distal end of the sheath 80 is at the surgical site, the magnetic medical device (either catheter 30 or 50) is deployed from the distal end of the sheath. This can be accomplished by pushing the proximal end of the magnetic medical device. Because the catheter is purposely made highly flexible, it can be difficult to push the medical device. A stylette can be inserted in the proximal end of the sheath to push the medical device from the sheath. A magnetic field can be temporarily aligned with the axis of the sheath 80 to help stiffen the elongate magnetic element, and facilitate its deployment from the sheath. A magnetic gradient can alternatively or additionally be applied to help pull the elongate magnetic element from the sheath. The front field gradient of a magnet could be used for this purpose.
As an alternative to navigating the magnetic medical device to the surgical site in a sheath 80, the device can-be navigated directly. The magnetic medical device is preferably highly flexible so that it is readily oriented and applied against structures at the surgical site. To facilitate its navigation to the surgical site, the catheter 30 (or 50) can be provided with a lumen 90, and as shown in
An elongate magnetic element adapted for use with the method of this invention, and adapted to be incorporated into medical devices of this invention is indicated generally as 36 in FIG. 8. The elongate magnetic element 56 is similar in construction to elongate magnetic element 36. The elongate magnetic element 36 comprises a flexible hollow tube 100, having a plurality of magnetic bodies 102, separated by spaces 104. The spaces 104 allow the elongate magnet element 36 to flex to accommodate the surface of a body structure to which it is applied. The magnetic bodies 102 are preferably cylinders of a permanent magnetic material, such as neodymium iron boron, or cylinders of a permeable magnetic material. The contacts 38 are preferably aligned with the magnetic bodies 102 rather than the spaces 104, so that they are firmly pressed into the tissue upon the application of a gradient. An alternate construction of the elongate magnetic element is indicated generally as 36' in FIG. 9. In elongate magnetic element 36', the magnetic bodies 102 are coils 106 of a magnetically responsive material, such as a permeable magnetic material (such as soft iron or hyperco) or a permanent magnetic material. A second alternate construction of the elongate magnetic element is indicated generally as 36" in FIG. 10. In elongate magnetic element 36", the magnetic bodies 102 comprise a single elongate coil 108 of a magnetically responsive material, such as a permeable magnetic material or a permanent magnetic material.
In a preferred construction of the catheter 30, the catheter comprises a continuous tube, with elongate magnet element being disposed in the distal portion of the tube. The proximal portion of the continuous can be made stiffer to improve the ability to advance the catheter by pushing, while leaving the distal end flexible to allow the elongate magnetic element to respond to applied magnetic fields and gradients. The continuous tube forms a tether for restraining the elongate magnetic element formed in the distal section against the pull of the magnetic gradient. The tube has a lumen for electrical leadlines, or cryogen pathway, or a fluid pathway for whatever medical device(s) is provided on the elongate magnetic element on the distal end.
In a preferred construction of the catheter 50, one or both of the tethers 58 and 60 excluding the elongate magnetic element 56 are hollow tubes, communicating with a lumen through the catheter. The tethers thus provide a continuous path through the catheter 50 to the elongate magnetic element for electric leadlines, a cryogen pathway, or a fluid pathway for whatever medical device(s) is provided on the elongate magnetic element. The tethers 58 and 60 are preferably highly flexible to allow the elongate magnetic element to freely respond to an applied magnetic field or gradient.
Because of the tendency of the elongate magnetic element to rigidly align with the applied magnetic field lines, which are typically straight when using the side field of a magnet, the elongate magnetic element may not conform to the curved surface of a body structure, such as the walls of the chamber of a heart, although the heart will conform somewhat to the catheter. An alternative embodiment of the elongate magnetic element indicated as 120 in
An alternative way-of increasing the conformability of the elongate magnetic element to a curved surface is to allow the magnetic bodies to pivot to remain aligned with the field, as the elongate magnetic member bends to conform to the surface to which it is applied. However, the magnetic bodies must be sufficiently spaced that they can pivot independently in the applied magnetic field. Thus, an alternative construction of an elongate magnetic device, indicated generally as 140 in
Operation
A magnetic medical device, such as catheter 30 or 50, is navigated to the surgical site within an operating region, for example a chamber of the heart. The catheter 30 or 50 can have contacts thereon such as electrodes for cardiac mapping or cardiac pacing, or contacts for cardiac tissue RF-ablation, ultrasonic ablation, or cryogenic ablation. Alternatively the catheter 30 or 50 could have injectors, or simply openings for delivering substances, such as saline for cooling the RF-ablation contacts, or therapeutic agents. Of course other diagnostic or therapeutic elements and devices could be provided on the catheters 30 and 50.
The catheter 30 or 50 can be navigated to the chamber of the heart in the distal end of a sheath 80. The sheath can be mechanically navigated, as is known in the art. It is also possible to magnetically navigate the distal end of the sheath, taking advantage of the elongate magnetic element 36 of the catheter 30 (or the elongate magnetic element 56 of the catheter 50). Once the distal end of the sheath 80 is at the surgical site, the catheter 30 or 50 is deployed by pushing the proximal end to eject it from the distal end of the sheath. A magnetic field can be applied to stiffen the elongate magnetic element 36 of catheter 30 (or the elongate magnetic element 56 of catheter 40), to facilitate its deployment from the end of the sheath.
Alternatively the catheters, and particularly catheter 30 can be navigated to the surgical site directly. This can be a simple mechanical navigation, with the assistance of a stiffening stylette 94, or it can be magnetically assisted navigation taking advantage of the elongate magnetic element that is part of the catheter. The front field of a magnet can be used to align the elongate magnetic element and apply a pulling gradient in the same direction as the magnetic field (as opposed to the side field utilized in the present invention which is generally oblique to the field direction). A standard curved catheter can be used to facilitate navigating the device to the desired chamber, where it can be deployed.
Once it is deployed, a magnetic field and gradient is applied to the magnetic element 36 of catheter 30 (or 56 of catheter 50). The field tends to align the elongate magnetic element with the local field lines while the gradient tends to pull the elongate magnetic element toward the wall of the heart chamber. The movement of the elongate magnetic element 36 is restrained by the proximal portion of the catheter 30. The movement of the elongate magnetic element 56 is restrained by the proximal portion of the catheter 50 and the tethers 58 and 60. The magnetic field direction is manipulated (typically by moving the magnet or magnets applying the field and gradient) to orient the elongate magnetic element in the desired orientation. Once in the desired orientation, the elongate magnetic element can be applied to the surface of the chamber wall by slacking the proximal end of the catheter 30 or 50. The elongate magnetic element is pulled by the magnetic gradient into contact with the wall of the chamber. The position of the elongate magnetic element can be tracked by the markers 40 (or 64 on catheter 50). Once the position of the elongate magnetic element can be located relative to the magnet(s) applying the magnetic field and gradient, the force applied by the elongate magnetic element can be determined, and controlled by varying the position of the magnet. Thus, the force with which the contacts on the elongate magnetic element are applied to the tissue can be ascertained and controlled.
When it is desired to reposition the elongate magnetic element, the magnet(s) can simply be manipulated to reorient the elongate magnetic element while the elongate magnetic element remains in contact with the surface of the chamber wall. Preferably however, the elongate magnetic is pulled out of contact with the chamber wall by tensioning the proximal end of the catheter 30 or 50, and the elongate magnetic element is re-oriented out of contact with the chamber wall, and reapplied by slacking the tension on the proximal end of the catheter 30 or 50.
When the procedure is completed, the catheter 30 or 50 is removed from the surgical site, for example retracting it into the sheath 50 and withdrawing the sheath, or by withdrawing the catheter directly.
An electrophysiology catheter constructed according to the principles of this invention is indicated generally as 200 in
The distal end 202 of the catheter 200 is navigated through the vasculature, and into the chamber of the heart. Once the distal end 202 of the catheter is in the chamber of the heart, a magnetic field and an oblique magnetic gradient are applied to the distal end. As shown in
The electrodes 212 are brought into contact with the wall of the chamber. RF energy is applied to the electrodes 212 via leads 214 (either simultaneously or serially). The RF energy ablates the tissue adjacent the electrodes forming a linear lesion useful in treating various tachyarrhythmias. The elongate magnetic element 210 can be pulled from the chamber wall by tensioning the proximal portion of the catheter 200. The elongate magnetic element 210 can be re-oriented by changing the magnetic field by repositioning andor reorienting the source of the field. The tension on the proximal portion of the catheter is slackened and the magnetic gradient pulls the elongate magnetic element back into contact with the chamber wall. RF energy can be applied to create another linear lesion by ablation. The process continues until the desired linear lesions have been formed, the intent being to create a continuous linear lesion build up from these segments.
An alternate construction of the catheter 200 is indicated generally as 200' in FIG. 16. Catheter 200' is similar in construction to catheter 200, and corresponding reference numerals indicate corresponding parts. However, unlike catheter 200, catheter 200' has a tether 216 extending from its distal end. The tether 216 passes through an opening in the wall of catheter, and then through the lumen to the proximal end, where the tether can be manipulated to change the shape of the elongate magnetic element 210 by expanding and contracting the loop 218.
Hastings, Roger N., Ritter, Rogers C., Hall, Andrew F.
Patent | Priority | Assignee | Title |
10004875, | Aug 24 2005 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
10028833, | Oct 21 2002 | Edwards Lifesciences Corporation | Tissue fastening systems and methods utilizing magnetic guidance |
10029008, | Nov 02 2009 | Pulse Therapeutics, Inc. | Therapeutic magnetic control systems and contrast agents |
10045817, | Nov 16 2010 | TVA Medical, Inc. | Devices and methods for forming a fistula |
10046139, | Aug 20 2010 | C. R. Bard, Inc. | Reconfirmation of ECG-assisted catheter tip placement |
10105121, | Nov 26 2007 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
10159734, | Nov 02 2009 | Pulse Therapeutics, Inc. | Magnetic particle control and visualization |
10165962, | Nov 26 2007 | C. R. Bard, Inc. | Integrated systems for intravascular placement of a catheter |
10231643, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
10231753, | Nov 26 2007 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
10238418, | Nov 26 2007 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
10258504, | Nov 27 2013 | Method of replacing a detached retina | |
10271762, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
10342575, | Nov 26 2007 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
10349890, | Jun 26 2015 | C R BARD, INC | Connector interface for ECG-based catheter positioning system |
10434278, | Mar 05 2013 | eZono AG | System for image guided procedure |
10449330, | Nov 26 2007 | C R BARD, INC | Magnetic element-equipped needle assemblies |
10524691, | Nov 26 2007 | C R BARD, INC | Needle assembly including an aligned magnetic element |
10537713, | May 25 2009 | STEREOTAXIS, INC | Remote manipulator device |
10602958, | Nov 26 2007 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
10603040, | Feb 09 2015 | TVA MEDICAL, INC | Methods for treating hypertension and reducing blood pressure with formation of fistula |
10625052, | Mar 14 2014 | TVA MEDICAL, INC | Fistula formation devices and methods therefor |
10639008, | Oct 08 2009 | C R BARD, INC | Support and cover structures for an ultrasound probe head |
10646241, | May 15 2012 | Pulse Therapeutics, Inc. | Detection of fluidic current generated by rotating magnetic particles |
10646666, | Aug 27 2014 | TVA MEDICAL, INC | Cryolipolysis devices and methods therefor |
10695046, | Jul 05 2005 | Edwards Lifesciences Corporation | Tissue anchor and anchoring system |
10695534, | Mar 14 2014 | TVA MEDICAL, INC | Fistula formation devices and methods therefor |
10751509, | Nov 26 2007 | C R BARD, INC | Iconic representations for guidance of an indwelling medical device |
10758155, | Sep 06 2011 | eZono AG | Imaging probe and method of obtaining position and/or orientation information |
10765343, | Sep 06 2011 | eZono AG | Imaging probe and method of obtaining position and/or orientation information |
10813997, | Nov 02 2009 | Pulse Therapeutics, Inc. | Devices for controlling magnetic nanoparticles to treat fluid obstructions |
10820885, | Jun 15 2012 | C R BARD, INC | Apparatus and methods for detection of a removable cap on an ultrasound probe |
10821217, | Mar 14 2013 | TVA MEDICAL, INC | Fistula formation devices and methods therefor |
10849695, | Nov 26 2007 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
10863920, | Feb 06 2014 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
10869717, | Oct 11 2012 | TVA Medical, Inc. | Devices and methods for fistula formation |
10874422, | Jan 15 2016 | TVA MEDICAL, INC | Systems and methods for increasing blood flow |
10912488, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
10918373, | Aug 31 2013 | Edwards Lifesciences Corporation | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
10932851, | May 19 2009 | AtriCure, Inc. | Magnetic navigation systems and methods |
10966630, | Nov 26 2007 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
10973584, | Jan 19 2015 | BARD ACCESS SYSTEMS, INC ; ROMEDEX INTERNATIONAL SRL | Device and method for vascular access |
10992079, | Oct 16 2018 | BARD ACCESS SYSTEMS, INC | Safety-equipped connection systems and methods thereof for establishing electrical connections |
11000207, | Jan 29 2016 | C R BARD, INC | Multiple coil system for tracking a medical device |
11000589, | Nov 02 2009 | Pulse Therapeutics, Inc. | Magnetic particle control and visualization |
11026630, | Jun 26 2015 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
11026743, | Jan 15 2016 | TVA MEDICAL, INC | Devices and methods for forming a fistula |
11027101, | Aug 22 2008 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
11051880, | Nov 16 2010 | TVA Medical, Inc. | Devices and methods for forming a fistula |
11103213, | Oct 08 2009 | C. R. Bard, Inc. | Spacers for use with an ultrasound probe |
11123099, | Nov 26 2007 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
11134915, | Nov 26 2007 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
11207070, | Feb 09 2015 | TVA Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
11207496, | Aug 24 2005 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
11219745, | Mar 14 2014 | TVA Medical, Inc. | Fistula formation devices and methods therefor |
11285028, | Sep 25 2016 | TVA MEDICAL, INC | Vascular stent devices and methods |
11419517, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
11432870, | Oct 04 2016 | Avent, Inc. | Cooled RF probes |
11529070, | Nov 26 2007 | C. R. Bard, Inc. | System and methods for guiding a medical instrument |
11590322, | Jan 15 2016 | TVA Medical, Inc. | Devices and methods for advancing a wire |
11612655, | Nov 02 2009 | Pulse Therapeutics, Inc. | Magnetic particle control and visualization |
11621518, | Oct 16 2018 | Bard Access Systems, Inc. | Safety-equipped connection systems and methods thereof for establishing electrical connections |
11660190, | Mar 13 2007 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
11707205, | Nov 26 2007 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
11707562, | Mar 14 2013 | TVA Medical, Inc. | Fistula formation devices and methods therefor |
11759254, | May 19 2009 | AtriCure, Inc. | Magnetic navigation systems and methods |
11779240, | Nov 26 2007 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
11826093, | Jan 15 2016 | TVA Medical, Inc. | Devices and methods for forming a fistula |
7166127, | Dec 23 2003 | Edwards Lifesciences Corporation | Tissue fastening systems and methods utilizing magnetic guidance |
7276044, | May 06 2001 | STEREOTAXIS, INC | System and methods for advancing a catheter |
7341063, | Feb 16 2000 | STEREOTAXIS, INC | Magnetic medical devices with changeable magnetic moments and method of navigating magnetic medical devices with changeable magnetic moments |
7346379, | May 21 2003 | STEREOTAXIS, INC | Electrophysiology catheter |
7416335, | Jul 15 2005 | STEREOTAXIS, INC | Magnetically shielded x-ray tube |
7431726, | Dec 23 2003 | Edwards Lifesciences Corporation | Tissue fastening systems and methods utilizing magnetic guidance |
7495537, | Aug 10 2005 | STEREOTAXIS, INC | Method and apparatus for dynamic magnetic field control using multiple magnets |
7537570, | Sep 11 2006 | STEREOTAXIS, INC | Automated mapping of anatomical features of heart chambers |
7543239, | Jun 04 2004 | STEREOTAXIS, INC | User interface for remote control of medical devices |
7567233, | Sep 06 2006 | STEREOTAXIS, INC | Global input device for multiple computer-controlled medical systems |
7603905, | Jul 08 2005 | STEREOTAXIS, INC | Magnetic navigation and imaging system |
7708696, | Jan 11 2005 | STEREOTAXIS, INC | Navigation using sensed physiological data as feedback |
7742803, | May 06 2005 | STEREOTAXIS, INC | Voice controlled user interface for remote navigation systems |
7747960, | Sep 06 2006 | STEREOTAXIS, INC | Control for, and method of, operating at least two medical systems |
7751867, | Dec 20 2004 | STEREOTAXIS, INC | Contact over-torque with three-dimensional anatomical data |
7756308, | Feb 07 2005 | STEREOTAXIS, INC | Registration of three dimensional image data to 2D-image-derived data |
7757694, | Oct 04 1999 | STEREOTAXIS, INC | Method for safely and efficiently navigating magnetic devices in the body |
7766856, | May 06 2001 | STEREOTAXIS, INC | System and methods for advancing a catheter |
7769444, | Jul 11 2005 | STEREOTAXIS, INC | Method of treating cardiac arrhythmias |
7771415, | Oct 04 1999 | STEREOTAXIS, INC | Method for safely and efficiently navigating magnetic devices in the body |
7772950, | Aug 10 2005 | STEREOTAXIS, INC | Method and apparatus for dynamic magnetic field control using multiple magnets |
7794407, | Oct 23 2006 | BARD ACCESS SYSTEMS, INC | Method of locating the tip of a central venous catheter |
7818076, | Jul 26 2005 | STEREOTAXIS, INC | Method and apparatus for multi-system remote surgical navigation from a single control center |
7831294, | Oct 07 2004 | STEREOTAXIS, INC | System and method of surgical imagining with anatomical overlay for navigation of surgical devices |
7961924, | Aug 21 2006 | STEREOTAXIS, INC | Method of three-dimensional device localization using single-plane imaging |
7961926, | Feb 07 2005 | STEREOTAXIS, INC | Registration of three-dimensional image data to 2D-image-derived data |
7966059, | Oct 04 1999 | STEREOTAXIS, INC | Rotating and pivoting magnet for magnetic navigation |
8024024, | Jun 27 2007 | STEREOTAXIS, INC | Remote control of medical devices using real time location data |
8060184, | Jun 28 2002 | STEREOTAXIS, INC | Method of navigating medical devices in the presence of radiopaque material |
8114032, | May 06 2001 | STEREOTAXIS, INC | Systems and methods for medical device advancement and rotation |
8135185, | Oct 20 2006 | STEREOTAXIS, INC | Location and display of occluded portions of vessels on 3-D angiographic images |
8142493, | Dec 23 2003 | Edwards Lifesciences Corporation | Method of heart valve repair |
8192374, | Jul 18 2005 | STEREOTAXIS, INC | Estimation of contact force by a medical device |
8192447, | Sep 29 2006 | Terumo Kabushiki Kaisha | Medical device and using method thereof |
8196590, | May 02 2003 | STEREOTAXIS, INC | Variable magnetic moment MR navigation |
8231618, | Nov 05 2007 | STEREOTAXIS, INC | Magnetically guided energy delivery apparatus |
8242972, | Sep 06 2006 | STEREOTAXIS, INC | System state driven display for medical procedures |
8244824, | Sep 06 2006 | STEREOTAXIS, INC | Coordinated control for multiple computer-controlled medical systems |
8273081, | Sep 08 2006 | STEREOTAXIS, INC | Impedance-based cardiac therapy planning method with a remote surgical navigation system |
8308628, | Nov 02 2009 | PULSE THERAPEUTICS, INC | Magnetic-based systems for treating occluded vessels |
8313422, | Nov 02 2009 | PULSE THERAPEUTICS, INC | Magnetic-based methods for treating vessel obstructions |
8369934, | Dec 20 2004 | STEREOTAXIS, INC | Contact over-torque with three-dimensional anatomical data |
8388541, | Nov 26 2007 | C R BARD, INC | Integrated system for intravascular placement of a catheter |
8388546, | Oct 23 2006 | BARD ACCESS SYSTEMS, INC | Method of locating the tip of a central venous catheter |
8419681, | Nov 18 2002 | STEREOTAXIS, INC | Magnetically navigable balloon catheters |
8430875, | May 19 2009 | Atricure, Inc | Magnetic navigation systems and methods |
8437833, | Oct 07 2008 | BARD ACCESS SYSTEMS, INC | Percutaneous magnetic gastrostomy |
8460371, | Oct 21 2002 | Edwards Lifesciences Corporation | Method and apparatus for performing catheter-based annuloplasty using local plications |
8478382, | Feb 11 2008 | C R BARD, INC | Systems and methods for positioning a catheter |
8512256, | Oct 23 2006 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
8529428, | Nov 02 2009 | PULSE THERAPEUTICS, INC | Methods of controlling magnetic nanoparticles to improve vascular flow |
8532743, | Aug 05 2010 | ST JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC | Movable magnet for magnetically guided catheter |
8715150, | Nov 02 2009 | PULSE THERAPEUTICS, INC | Devices for controlling magnetic nanoparticles to treat fluid obstructions |
8774907, | Oct 23 2006 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
8781555, | Nov 26 2007 | C R BARD, INC | System for placement of a catheter including a signal-generating stylet |
8784336, | Aug 24 2005 | C R BARD, INC | Stylet apparatuses and methods of manufacture |
8799792, | Sep 06 2006 | STEREOTAXIS, INC | Workflow driven method of performing multi-step medical procedures |
8801693, | Oct 29 2010 | C R BARD, INC | Bioimpedance-assisted placement of a medical device |
8806359, | Sep 06 2006 | STEREOTAXIS, INC | Workflow driven display for medical procedures |
8845723, | Mar 13 2007 | Edwards Lifesciences Corporation | Systems and methods for introducing elements into tissue |
8849382, | Nov 26 2007 | C R BARD, INC | Apparatus and display methods relating to intravascular placement of a catheter |
8858455, | Oct 23 2006 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
8864822, | Dec 23 2003 | Edwards Lifesciences Corporation | Devices and methods for introducing elements into tissue |
8911461, | Mar 13 2007 | Edwards Lifesciences Corporation | Suture cutter and method of cutting suture |
8926491, | Nov 02 2009 | Pulse Therapeutics, Inc. | Controlling magnetic nanoparticles to increase vascular flow |
8951285, | Jul 05 2005 | Edwards Lifesciences Corporation | Tissue anchor, anchoring system and methods of using the same |
8951286, | Jul 05 2005 | Edwards Lifesciences Corporation | Tissue anchor and anchoring system |
8971994, | Feb 11 2008 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
8979923, | Oct 21 2002 | Edwards Lifesciences Corporation | Tissue fastening systems and methods utilizing magnetic guidance |
9017323, | Nov 16 2010 | TVA MEDICAL, INC | Devices and methods for forming a fistula |
9039702, | Nov 16 2010 | TVA Medical, Inc. | Devices and methods for forming a fistula |
9111016, | Jul 06 2007 | STEREOTAXIS, INC | Management of live remote medical display |
9125578, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
9211107, | Nov 07 2011 | C R BARD, INC | Ruggedized ultrasound hydrogel insert |
9227078, | Sep 29 2006 | Terumo Kabushiki Kaisha | Medical device and using method thereof |
9257220, | Mar 05 2013 | eZono AG | Magnetization device and method |
9259218, | Feb 26 2013 | Edwards Lifesciences Corporation | Tissue anchor and anchoring system |
9265443, | Oct 23 2006 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
9314222, | Jul 07 2005 | STEREOTAXIS, INC | Operation of a remote medical navigation system using ultrasound image |
9339206, | Jun 12 2009 | BARD ACCESS SYSTEMS, INC | Adaptor for endovascular electrocardiography |
9339664, | Nov 02 2009 | Pulse Therapetics, Inc. | Control of magnetic rotors to treat therapeutic targets |
9345422, | Oct 23 2006 | Bard Acess Systems, Inc. | Method of locating the tip of a central venous catheter |
9345498, | Nov 02 2009 | Pulse Therapeutics, Inc. | Methods of controlling magnetic nanoparticles to improve vascular flow |
9358111, | Mar 13 2007 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
9358112, | Apr 24 2001 | Edwards Lifesciences Corporation | Method and apparatus for catheter-based annuloplasty using local plications |
9415188, | Oct 29 2010 | C R BARD, INC | Bioimpedance-assisted placement of a medical device |
9445734, | Jun 12 2009 | BARD ACCESS SYSTEMS, INC | Devices and methods for endovascular electrography |
9456766, | Nov 26 2007 | C R BARD, INC | Apparatus for use with needle insertion guidance system |
9459087, | Mar 05 2013 | eZono AG | Magnetic position detection system |
9463302, | Aug 05 2010 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Movable magnet for magnetically guided catheter |
9486276, | Oct 11 2012 | TVA MEDICAL, INC | Devices and methods for fistula formation |
9492097, | Nov 26 2007 | C R BARD, INC | Needle length determination and calibration for insertion guidance system |
9521961, | Nov 26 2007 | C R BARD, INC | Systems and methods for guiding a medical instrument |
9526440, | Nov 26 2007 | C.R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
9532724, | Jun 12 2009 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
9549685, | Nov 26 2007 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
9554716, | Nov 26 2007 | C R BARD, INC | Insertion guidance system for needles and medical components |
9554939, | Nov 27 2013 | Magnetic retinal patch | |
9597008, | Sep 06 2011 | eZono AG | Imaging probe and method of obtaining position and/or orientation information |
9636031, | Nov 26 2007 | C.R. Bard, Inc. | Stylets for use with apparatus for intravascular placement of a catheter |
9649048, | Nov 26 2007 | C R BARD, INC | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
9681823, | Nov 26 2007 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
9750566, | May 19 2009 | Atricure, Inc | Magnetic navigation systems and methods |
9750608, | Mar 13 2007 | Edwards Lifesciences Corporation | Systems and methods for introducing elements into tissue |
9814454, | Jul 05 2005 | Edwards Lifesciences Corporation | Tissue anchor and anchoring system |
9833169, | Oct 23 2006 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
9839372, | Feb 06 2014 | C R BARD, INC | Systems and methods for guidance and placement of an intravascular device |
9883878, | May 15 2012 | PULSE THERAPEUTICS, INC | Magnetic-based systems and methods for manipulation of magnetic particles |
9901714, | Aug 22 2008 | C R BARD, INC | Catheter assembly including ECG sensor and magnetic assemblies |
9907513, | Oct 07 2008 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
9999371, | Nov 26 2007 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
D699359, | Aug 09 2011 | C R BARD, INC | Ultrasound probe head |
D724745, | Aug 09 2011 | C R BARD, INC | Cap for an ultrasound probe |
D754357, | Aug 09 2011 | C. R. Bard, Inc. | Ultrasound probe head |
Patent | Priority | Assignee | Title |
3794041, | |||
5776080, | Aug 12 1992 | Boston Scientific Scimed, Inc | Shaft movement control apparatus |
5911720, | Nov 26 1996 | EP Technologies, Inc. | Ablation catheter with segmented tip |
6126647, | May 17 1999 | SYNCRO MEDICAL INNOVATIONS, INC | Magnetically guided catheter with sensor |
6129685, | Feb 09 1994 | UNIVERSITY OF IOWA RESEARCH FOUNDATION, THE | Stereotactic hypothalamic obesity probe |
6272370, | Aug 07 1998 | STEREOTAXIS, INC | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 05 2011 | STEREOTAXIS, INC | COWEN HEALTHCARE ROYALTY PARTNERS II, L P , AS LENDER | SECURITY AGREEMENT | 027346 | /0001 | |
Aug 28 2017 | STEREOTAXIS, INC | COWEN HEALTHCARE ROYALTY PARTNERS II, L P | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 043733 | /0376 | |
Aug 28 2017 | COWEN HEALTHCARE ROYALTY PARTNERS II, L P | STEREOTAXIS, INC | CORRECTIVE ASSIGNMENT TO CORRECT THE REVERSAL OF ASSIGNOR AND ASSIGNEE PREVIOUSLY RECORDED ON REEL 043733 FRAME 0376 ASSIGNOR S HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST | 044269 | /0282 |
Date | Maintenance Fee Events |
Sep 28 2006 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Sep 24 2010 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Nov 07 2014 | REM: Maintenance Fee Reminder Mailed. |
Apr 01 2015 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Apr 01 2006 | 4 years fee payment window open |
Oct 01 2006 | 6 months grace period start (w surcharge) |
Apr 01 2007 | patent expiry (for year 4) |
Apr 01 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 01 2010 | 8 years fee payment window open |
Oct 01 2010 | 6 months grace period start (w surcharge) |
Apr 01 2011 | patent expiry (for year 8) |
Apr 01 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 01 2014 | 12 years fee payment window open |
Oct 01 2014 | 6 months grace period start (w surcharge) |
Apr 01 2015 | patent expiry (for year 12) |
Apr 01 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |